SOURCES SOUGHT
A -- ATOPIC DERMATITIS AND VACCINIA IMMUNIZATION - ANIMAL STUDIES
- Notice Date
- 12/4/2002
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Contract Management Branch 6700 B Rockledge Room 2230 MSC7612, Bethesda, MD, 20892-7605
- ZIP Code
- 20892-7605
- Solicitation Number
- Reference-Number-B-301(2)
- Archive Date
- 1/3/2003
- Point of Contact
- Paquetta Myrick-Hancock, Contract Specialist, Phone 301-496-0612, Fax 301-480-5253, - Paul McFarlane, Senior Contracting Officer, Phone 301-496-0349, Fax 301-402-0972,
- E-Mail Address
-
PMHancock@niaid.nih.gov, pm24v@nih.gov
- Description
- The Division of Allergy, Immunology and Transplantation (DAIT) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), DHHS is seeking capability statements from organizations with the expertise to establish an Animal Studies Consortium. The Animal Studies Consortium will be one of three components of an Atopic Dermatitis Vaccinia Network that will be created via contract awards in early fiscal year 2004. The Network will have three components: a Clinical Studies Consortium, an Animal Studies Consortium, and a Statistical and Data Coordinating Center. Each component will be established under separate contracts. Subcontracting will be encouraged. The purpose of the Animal Studies Consortium is to use state-of-the-art technology to define the functions of the immune system in mice or other animal models of atopic dermatitis (AD), and then to determine the immune response of these mice to vaccinia and surrogate viruses. These studies should provide important information for the future design of safer and more effective vaccines for AD patients. The tasks that the Animal Studies Consortium must fulfill will be coordinated with the Clinical Studies Consortium and the Statistical and Data Coordinating Center. Organizations capable of fulfilling this effort, at a minimum, must be able to: 1) Establish an Animal Studies Consortium consisting of institutions capable of providing the scientific and administrative expertise necessary to perform studies in animal models of AD. 2) Manage an organizational plan that must include processes for: a) establishing research priorities; b) reviewing, modifying, approving and disapproving research studies; c) allocating resources; d) monitoring and evaluating progress and performance; e) redirecting scientific focus and reallocating resources; and f) establishing and maintaining effective working relationships. 3) Provide input to a Network Executive Committee capable of being the governing body of the Network for all three components. 4) Design protocols and conduct animal studies that: a) utilize existing and newly developed mouse or other animal models to evaluate immune and gene expression responses following viral challenge with vaccinia or surrogate viruses; and b) correlate the results of these studies with those being performed by the Clinical Studies Consortium. 5) Provide appropriate resources critical to scientific and technical support in a cost-effective manner and be prepared to access bio-containment facilities should the need arise. 6) Ensure an orderly transition of contract-related activities and materials to a successor Contractor or the Government at contract completion. Interested parties must submit a written capability statement, inclusive of references, that identifies the organization's ability to perform the efforts described above. The NAICS Code applicable to this requirement is 541710. The small business size standard is 500 employees. Capability statements must identify the business status of the organization (i.e. educational institution, non-profit, large business, small business, 8 (a), or other corporate or non-corporate entity). This announcement is not a request for competitive proposals. A solicitation is not available at this time and the Government is not committed to award a contract based on the information contained in this notice. Capability statements are due within 15 calendar days of the publication of this notice and should be addressed to Paquetta Myrick-Hancock, Contract Specialist, at the address shown above or emailed to her attention. NO FAXES PLEASE. See FEDBIZOPPS note 25.
- Record
- SN00216351-W 20021206/021205073924 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |